Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-based retrospective cohort study

ObjectiveNon-small cell lung cancer (NSCLC) constitutes approximately 85% of lung cancer cases, with 20%–30% of patients diagnosed at stage III. While multimodal therapy is the standard for treating locally advanced NSCLC, the role of PORT remains controversial. This study seeks to evaluate the effe...

Full description

Bibliographic Details

Published in:	Frontiers in Surgery
Main Authors:	Diyang Zhu, Yuanyuan Xiao, Shancheng He, Baochang Xie, Wenqi Zhao, Yuhui Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	non-small cell lung cancer postoperative radiotherapy overall survival positive lymph nodes stage IIIA pathologic N2
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2024.1506854/full